Latvia vs Venezuela: Access to anti-retroviral drugs, female (%)
Latvia
54.0%
in 2024
Venezuela
54.0%
in 2024
Latvia rank
114th
Venezuela rank
114th
Access to anti-retroviral drugs, female (%) over time
- Latvia
- Venezuela
How they compare
Latvia currently reports 54.0% against 54.0% in Venezuela, a difference of 0.0%.
The two have swapped places 2 times across 23 shared years of data; in 2000 it was Venezuela ahead.
Latvia ranks 114th and Venezuela ranks 114th of 141 countries.
Venezuela has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | Venezuela | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.5% | 18.0% | 15.5% | Venezuela |
| 2010s | 20.4% | 49.2% | 28.8% | Venezuela |
| 2020s | 50.3% | 53.7% | 3.3% | Venezuela |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Latvia or Venezuela?
- Latvia, at 54.0% against 54.0% in Venezuela as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Latvia and Venezuela?
- 0.0%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Venezuela?
- 23 years are reported by both, from 2000 to 2024.
- How do Latvia and Venezuela rank globally for access to anti-retroviral drugs, female?
- Latvia ranks 114th and Venezuela ranks 114th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.